Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Non-positive Airway Pressure Therapies for Obstructive Sleep Apnoea and Central Sleep Apnoea
Cardiac failure review, 2026;12:e29
Pulsatile liraglutide on a biased tirzepatide background: a hypothesis
Frontiers in endocrinology, 2026;17:1922908
Cardiovascular-Kidney-Metabolic Syndrome and Its Hepatic Dimension: A Narrative Review
Medicina (Kaunas, Lithuania), 2026;62(9)
Skeletal Muscle Effects of GLP 1 Receptor Agonists: Molecular Mechanisms and Comparative Insights on Semaglutide and Tirzepatide, a Narrative Review
International journal of molecular sciences, 2026;27(18)
Glycemic Outcomes Associated With GLP-1 Receptor Agonist Shortages in Type 2 Diabetes
PRiMER (Leawood, Kan.), 2026;10:33
Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review
World journal of clinical pediatrics, 2026;15(3):118730
Semaglutide and Tirzepatide for the treatment of MASH: What Works, What’s Coming, and What’s Missing
Digestion, 2026;:1
Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta-Analysis of Randomized Controlled Trials
Journal of the American Heart Association, 2026;:e044249
Water-Soluble, Enzyme-Degradable, and Hydrolyzable STAR Particles for Enhanced Drug Delivery to Skin
Advanced healthcare materials, 2026;:e71569
Anesthetic Safety and Perioperative Outcomes in GLP-1 Receptor Agonist-Treated Patients Undergoing Lipoabdominoplasty
Aesthetic plastic surgery, 2026
Cell death-induced chronic inflammation as a therapeutic target for metabolic dysfunction-associated steatohepatitis
Pharmacology & therapeutics, 2026;:109123
GLP-1 Receptor Agonists in Epilepsy: Separating Evidence for Antiseizure Activity, Neuroprotection, and Disease Modification
International journal of molecular sciences, 2026;27(18)
Cardiometabolic and atherosclerotic cardiovascular disease outcomes associated with tirzepatide: insights from a 1-year multicenter observational study
Journal of the Endocrine Society, 2026;10(10):bvag210
Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty
Journal of shoulder and elbow arthroplasty, 2026;10(4):100088
Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials
Endocrinology, diabetes & metabolism;9(5):e70313
Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics
Diabetes, obesity & metabolism, 2026
A Biweekly GLP-1R Agonist Designed With Drug-Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability
Diabetes, obesity & metabolism, 2026
Association of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study
International journal of cardiology, 2026;:134773
Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis
PeerJ, 2026;14:e21713